- 24 h
- letzte 200 News
| Zeit | Aktuelle Nachrichten | ||
|---|---|---|---|
| Do | Ares Capital Corporation (ARCC): A Bull Case Theory | ||
| Do | SLB N.V. (SLB): A Bull Case Theory | ||
| Do | Dynatrace, Inc. (DT): A Bull Case Theory | ||
| Do | Exelixis, Inc. (EXEL): A Bull Case Theory | ||
| Do | Inspire Medical Systems, Inc. (INSP): A Bull Case Theory | ||
| Do | Raymond James Touts Newmont Corporation (NEM) Low-Risk Gold Business Model, Hikes Price Target | ||
| Do | Economic Consequences of Mass Moves in the U.S. | ||
| Do | USA Rare Earth, Inc. (USAR) Eyes Commercial Production at Round Top Heavy Rare Earth Deposit in Texas | ||
| Do | Goldman Sachs Lifts Commercial Metals Company (CMC) Price Target Buoyed By Position in Steel Market | ||
| Do | Vale S.A. (VALE) Faces Diverging Analyst Calls Amid Iron Ore Market Shifts | ||
| Do | Energy Fuels Inc. (UUUU) Exceeds Guidance, Asserts Dominance as Uranium Producer | ||
| Do | Franco-Nevada Corporation (FNV) Upgraded to Outperform, Price Target Lifted to $250 | ||
| Do | Agnico Eagle Mines Limited (AEM) Increases Stake in Osisko as it Targets High Geological Potential Projects | ||
| Do | Here's What Analysts Think About Banco Bilbao Vizcaya Argentaria (BBVA) | ||
| Do | What Does Wall Street Think About Banco Santander (SAN)? | ||
| Do | Why is Equinor ASA (EQNR) One of the Best Affordable Stocks Under $30? | ||
| Do | Piper Believes Stellantis N.V. (STLA) Has the Potential for "Rapid Upside" - Here's Why | ||
| Do | Barclays Maintains Overweight Rating on Energy Transfer LP (ET) | ||
| Do | This is What Analysts Are Saying About Cenovus Energy Inc. (CVE) | ||
| Do | Why Pfizer Inc. (PFE) is One of the Best Affordable Stocks Under $30 | ||
| Do | Here is What Analysts Think About AT&T Inc. (T) | ||
| Do | Wall Street Forecasts 42.31% Upside To Terns Pharmaceuticals, Inc. (TERN) | ||
| Do | Structure Therapeutics Inc. (GPCR) Has Gained Over 130% in 3 Months. Here is Why | ||
| Do | Edgewise Therapeutics, Inc. (EWTX) Outlines Priorities For 2026 | ||
| Do | Kymera Therapeutics, Inc. (KYMR) Up 28% in 3M, Analysts See Further Upside |
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und .